1. Home
  2. FNKO vs EDIT Comparison

FNKO vs EDIT Comparison

Compare FNKO & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Funko Inc.

FNKO

Funko Inc.

HOLD

Current Price

$3.62

Market Cap

192.7M

ML Signal

HOLD

Logo Editas Medicine Inc.

EDIT

Editas Medicine Inc.

HOLD

Current Price

$2.04

Market Cap

202.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNKO
EDIT
Founded
2017
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
192.7M
202.1M
IPO Year
2017
2016

Fundamental Metrics

Financial Performance
Metric
FNKO
EDIT
Price
$3.62
$2.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$5.50
$4.50
AVG Volume (30 Days)
792.0K
1.9M
Earning Date
03-05-2026
03-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$928,842,000.00
$46,383,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$10.54
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.22
$0.91
52 Week High
$14.28
$4.54

Technical Indicators

Market Signals
Indicator
FNKO
EDIT
Relative Strength Index (RSI) 57.00 39.21
Support Level $3.47 $1.99
Resistance Level $3.77 $2.28
Average True Range (ATR) 0.22 0.13
MACD 0.02 0.01
Stochastic Oscillator 49.32 23.08

Price Performance

Historical Comparison
FNKO
EDIT

About FNKO Funko Inc.

Funko Inc is an USA based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.

Share on Social Networks: